In the present study, 131I-antiAFPMcAb-GCV-BSA nanospheres targeted to AFP-positive tumors were constructed and their characteristics and hepatoma-targeting in vitro and in vivo were investigated, with the aim of providing theoretical and experimental insights for further high-efficiency radiation-gene therapy of hepatoma. The gene discussed is AFP; the disease is hepatocellular carcinoma.